Our friend, independent researcher Kenzi Riboulet-Zemouli, published article addressing conceptual issues with the terminology of Cannabis and cannabinoids on the last days of 2020.
The article presents results of the research undertaken in parallel to the three-year assessment of Cannabis derivatives by the World Health Organisation. The scope is limited to Cannabis products intended for human incorporation (internal and topical consumption). Primarily embedded in pharmacognosy, the study incorporates a wide range of scholarly and grey literature, folk knowledge, archives, pharmacopœias, international law, field pharmacy, clinical and herbal medicine data, under a philosophical scrutiny. Generic and Cannabis-specific nomenclatural frames are compared to determine the extent to which they coincide or conflict.
Article ‘Cannabis’ ontologies I: Conceptual issues with Cannabis and cannabinoids terminology is available following this link>>>.
Kenzi announced that the part II of the study (‘Cannabis’ ontologies II) will follow this year with a series of more practical, concrete outputs and a proposed evidence-based nomenclature of Cannabis sativa products and cannabinoid compounds.